A Guide to Lung Cancer Care Pathways in Singapore
Lung
cancer is one of the leading causes of cancer-related deaths in Singapore and
globally. Despite advancements in medical technology, the disease often
presents at an advanced stage due to a lack of early symptoms. However,
Singapore’s healthcare system provides a structured and multi-layered approach
to lung cancer care, involving early detection, diagnosis, multidisciplinary
treatment planning, and ongoing support. This article outlines the key stages
in the lung cancer care pathway in Singapore.
Early
Detection and Diagnosis
Early
detection significantly improves the chances of successful treatment. In
Singapore, lung cancer screening is typically recommended for high-risk
individuals—especially long-term smokers aged 55 and above, or those with a
significant history of exposure to risk factors such as secondhand smoke or
occupational carcinogens.
Low-dose
computed tomography (LDCT) is the preferred screening tool, capable of
identifying small nodules before symptoms appear. If a suspicious lesion is
found, further diagnostic steps such as biopsy, bronchoscopy, or PET-CT scans
may be used to determine the nature and extent of the disease.
Types and
Staging
Lung
cancer is broadly classified into two main types:
·
Non-Small Cell Lung Cancer
(NSCLC): The most
common form, accounting for about 85% of cases.
·
Small Cell Lung Cancer (SCLC): A more aggressive type that spreads quickly.
Accurate
staging is essential for determining the appropriate treatment plan. Staging
involves assessing the size of the tumor, lymph node involvement, and whether
the cancer has spread to other organs. Singapore's hospitals typically follow
the TNM (Tumor, Node, Metastasis) staging system and may use additional
molecular testing to identify specific mutations (e.g., EGFR, ALK) that can
inform targeted therapies.
Multidisciplinary
Treatment Planning
Once a
diagnosis is confirmed, a multidisciplinary team (MDT) of specialists—including
medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists,
radiologists, and pathologists—reviews the patient’s condition and formulates a
personalised treatment plan.
This
team-based approach is standard in both public institutions such as the
National Cancer Centre Singapore (NCCS) and the National University Cancer
Institute (NCIS), as well as private hospitals across the country.
Treatment
Modalities
The choice
of treatment depends on the type, stage, and molecular profile of the cancer,
as well as the patient’s overall health and preferences. Common treatment
options include:
1. Surgery
Surgery
may be an option for early-stage NSCLC and involves removing the tumor and part
of the lung (lobectomy or pneumonectomy). Minimally invasive techniques such as
video-assisted thoracoscopic surgery (VATS) are increasingly used.
2. Radiation
Therapy
Radiation
therapy is often used for patients who are not suitable for surgery or in
combination with chemotherapy for locally advanced disease. Techniques such as
stereotactic body radiation therapy (SBRT) allow precise targeting of tumors.
3. Chemotherapy
Chemotherapy
is used across various stages, either alone or in combination with surgery or
radiation. It’s especially common for SCLC, which tends to respond well to
systemic treatment.
4. Targeted
Therapy
Patients
with specific genetic mutations (e.g., EGFR, ALK, ROS1) may benefit from
targeted drugs that interfere with cancer cell growth. These therapies are
available in Singapore and often cause fewer side effects than traditional
chemotherapy.
5. Immunotherapy
Immunotherapy
drugs, such as immune checkpoint inhibitors, help the body’s immune system
recognize and attack cancer cells. These are generally used for advanced NSCLC
and may be combined with chemotherapy.
Supportive
and Palliative Care
Throughout
the treatment journey, supportive care is critical in managing symptoms, side
effects, and overall well-being. Services may include:
·
Pain
management
·
Nutritional
counseling
·
Respiratory
therapy
·
Psychological
support
·
Palliative
care for advanced cases
Hospitals
and cancer centres in Singapore offer integrated support programs that involve
both medical and allied health professionals.
Access to
Care
Lung cancer care is available in both public and private sectors.
Public hospitals offer subsidised rates for eligible patients through schemes
like MediSave, MediShield Life, and government assistance programs. Private
care is also widely available and often chosen for faster access and customised
care.
Conclusion
Singapore
provides a structured and well-resourced pathway for lung cancer care—from
early detection and diagnosis to advanced therapies and supportive services.
The multidisciplinary approach ensures that patients receive comprehensive care
tailored to their specific condition. As research advances and awareness grows,
continued improvements in early screening and treatment options offer hope for
better outcomes for those affected by lung cancer.
Comments
Post a Comment